|
|
|
42
|
2931W
|
VASOPRESSIN 20U/ML INJ (SLS)
|
VASOPRESSIN
|
VASOPRESSIN
|
5X1ML
|
BQ
|
92.69
|
18.54
|
VIAL
|
6
|
AMP
|
SLS
|
SAMARTH LIFE SCIENCES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
6828
|
PITUITARY
|
2026-04-01
|
2028-03-31
|
|
IV
|
0
|
PITUITARY
|
|
|
|
|
40
|
2931Y
|
VASMED 20U/ML INJ (UBI/RXP) VASOPRESSIN
|
VASOPRESSIN
|
VASMED
|
1ML AMP
|
BQ
|
10.47
|
10.47
|
INJECTION
|
0
|
AMP
|
UBI
|
UNITED BIOTECH (P) LIMITED
|
RXP
|
RX PRO INC
|
|
6828
|
PITUITARY
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
HORMONES AND SYNTHETIC SUBSTITUTES
|
|
|
|
|
42
|
2931Z
|
VASOPRESSIN 20U/ML INJ (FSB)
|
VASOPRESSIN
|
VASOPRESSIN
|
5X1ML
|
BQ
|
64.10
|
12.82
|
AMPP
|
6
|
|
FSB
|
FLAGSHIP BIOTECH
|
STO
|
BRYDEN STOKES LTD
|
|
6828
|
PITUITARY
|
2026-04-01
|
2028-03-31
|
|
IV/IM/SC
|
0
|
PITUITARY
|
2026-03-05
|
|
|
|
40
|
29426
|
HYDROXYPROGESTERONE 250MG/ML INJ (MON/PHA)
|
HYDROXYPROGESTERONE
|
HYDROXYPROGESTERONE
|
1ML AMP
|
BQ
|
3.62
|
3.62
|
INJECTION
|
0
|
AMP
|
MON
|
MONTAGE PHARMACEUTICALS
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
6832
|
PROGESTINS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
HORMONES AND SYNTHETIC SUBSTITUTES
|
|
|
|
|
41
|
29428
|
HYDROXYPROGESTERONE 250MG/ML INJ (MON)
|
HYDROXYPROGESTERONE
|
HYDROXYPROGESTERONE
|
5X1ML
|
BQ
|
12.88
|
2.577
|
AMP
|
0
|
BOX
|
MON
|
MONTAGE PHARMACEUTICALS
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
6832
|
PROGESTINS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
PROGESTINS
|
|
|
|
|
42
|
29428
|
HYDROXYPROGESTERONE 250MG/ML INJ (MON)
|
HYDROXYPROGESTERONE
|
HYDROXYPROGESTERONE
|
5X1ML
|
BQ
|
13.18
|
2.64
|
AMPG
|
0
|
AMP
|
MON
|
MONTAGE PHARMACEUTICALS
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
6832
|
PROGESTINS
|
2026-04-01
|
2028-03-31
|
|
IV
|
0
|
PROGESTINS
|
|
|
|
|
42
|
29429
|
LEGESTRO 250MG/ML INJ (JLP) HYDROXYPROGESTERONE
|
HYDROXYPROGESTERONE
|
LEGESTRO
|
10X1ML
|
BQ
|
23.11
|
23.11
|
AMPG
|
0
|
AMP
|
JLP
|
JOHN LEE PHARMACEUTICALS
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
6832
|
PROGESTINS
|
2026-04-01
|
2028-03-31
|
|
IM
|
0
|
PROGESTINS
|
|
|
|
|
40
|
2951D
|
APO-MEDROXY 10MG TAB (APO/COL)
|
MEDROXYPROGESTERONE
|
APO-MEDROXY
|
100'S
|
A
|
13.59
|
0.14
|
TABLET
|
10
|
TAB
|
APO
|
APOTEX INC.
|
COL
|
COLLINS LTD
|
|
6832
|
PROGESTINS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
HORMONES AND SYNTHETIC SUBSTITUTES
|
|
|
|
|
40
|
2951F
|
PROVERA 10MG TAB (PFI/STO) MEDROXYPROGESTERON
|
MEDROXYPROGESTERONE
|
PROVERA
|
10'S
|
C
|
6.82
|
0.68
|
TABLET
|
0
|
TAB
|
PFI
|
PFIZER CORPORATION
|
STO
|
BRYDEN STOKES LTD
|
|
6832
|
PROGESTINS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
HORMONES AND SYNTHETIC SUBSTITUTES
|
|
|
|
|
41
|
2951F
|
PROVERA 10MG TAB (PFI) MEDROXYPROGESTERO (C)
|
MEDROXYPROGESTERONE
|
PROVERA
|
10'S
|
C
|
6.88
|
0.6877
|
TAB
|
10
|
BOX
|
PFI
|
PFIZER CORPORATION
|
STO
|
BRYDEN STOKES LTD
|
|
6832
|
PROGESTINS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
PROGESTINS
|
|
|
|
|
42
|
2951F
|
PROVERA 10MG TAB (PFI) MEDROXYPROGE
|
MEDROXYPROGESTERONE
|
PROVERA
|
10'S
|
A
|
6.88
|
0.69
|
TAB
|
10
|
BOTT
|
PFI
|
PFIZER CORPORATION
|
STO
|
BRYDEN STOKES LTD
|
|
6832
|
PROGESTINS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
6
|
PROGESTINS
|
|
|
|
|
41
|
2951K
|
APO-MEDROXY 10MG TAB (APO)
|
MEDROXYPROGESTERONE
|
APO-MEDROXY
|
100'S
|
A
|
13.86
|
0.1386
|
TAB
|
10
|
BOTT
|
APO
|
APOTEX INC.
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
6832
|
PROGESTINS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
PROGESTINS
|
|
|
|
|
40
|
29532
|
DEPO-PROVERA 150MG/ML INJ (PFI/STO) MEDROXYPR
|
MEDROXYPROGESTERONE
|
DEPO-PROVERA
|
1ML VIAL
|
C
|
17.51
|
17.51
|
INJECTION
|
0
|
VIAL
|
PFI
|
PFIZER CORPORATION
|
STO
|
BRYDEN STOKES LTD
|
|
6812
|
CONTRACEPTIVES
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
HORMONES AND SYNTHETIC SUBSTITUTES
|
|
|
|
|
41
|
29532
|
DEPO-PROVERA 150MG/ML INJ (PFI) MEDROXYP (C)
|
MEDROXYPROGESTERONE
|
DEPO-PROVERA
|
1ML VIAL
|
C
|
17.67
|
17.6691
|
VIAL
|
1
|
VIAL
|
PFI
|
PFIZER CORPORATION
|
STO
|
BRYDEN STOKES LTD
|
|
6812
|
CONTRACEPTIVES
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
CONTRACEPTIVES
|
|
|
|
|
42
|
29532
|
DEPO-PROVERA 150MG/ML INJ (PFI) MED
|
MEDROXYPROGESTERONE
|
DEPO-PROVERA
|
1ML VIAL
|
C
|
17.67
|
17.67
|
VIAL
|
1
|
VIAL
|
PFI
|
PFIZER CORPORATION
|
STO
|
BRYDEN STOKES LTD
|
|
6812
|
CONTRACEPTIVES
|
2026-04-01
|
2028-03-31
|
|
IV
|
0
|
CONTRACEPTIVES
|
|
|
|
|
41
|
2953G
|
MEDROXYPROGESTERONE 150MG/ML INJ (KWA) (C)
|
MEDROXYPROGESTERONE
|
MEDROXYPROGESTERONE
|
1ML VIAL
|
C
|
4.81
|
4.8114
|
VIAL
|
1
|
VIAL
|
KWA
|
KWALITY PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
6812
|
CONTRACEPTIVES
|
2024-04-01
|
2026-03-31
|
|
IM
|
0
|
CONTRACEPTIVES
|
|
|
|
|
40
|
29555
|
APO-MEDROXY 100MG TAB (APO/COL)
|
MEDROXYPROGESTERONE
|
APO-MEDROXY
|
100'S
|
C
|
40.77
|
0.41
|
TABLET
|
0
|
TAB
|
APO
|
APOTEX INC.
|
COL
|
COLLINS LTD
|
|
6832
|
PROGESTINS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
HORMONES AND SYNTHETIC SUBSTITUTES
|
|
|
|
|
42
|
29555
|
AAP-MEDROXY 100MG TAB (APO) MEDROX (C)
|
MEDROXYPROGESTERONE
|
AAP-MEDROXY
|
100'S
|
C
|
89.51
|
0.90
|
TAB
|
30
|
BOTT
|
APO
|
APOTEX INC.
|
COL
|
AVENTA BARBADOS
|
|
6832
|
PROGESTINS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
6
|
PROGESTINS
|
|
|
|
|
41
|
29556
|
APO-MEDROXY 100MG TAB (APO) (C)
|
MEDROXYPROGESTERONE
|
APO-MEDROXY
|
100'S
|
C
|
41.59
|
0.4159
|
TAB
|
30
|
BOTT
|
APO
|
APOTEX INC.
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
6832
|
PROGESTINS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
PROGESTINS
|
|
|
|
|
40
|
29563
|
APO-MEDROXY 2.5MG TAB (APO/COL)
|
MEDROXYPROGESTERONE
|
APO-MEDROXY
|
100'S
|
A
|
5.98
|
0.06
|
TABLET
|
20
|
TAB
|
APO
|
APOTEX INC.
|
COL
|
COLLINS LTD
|
|
6832
|
PROGESTINS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
HORMONES AND SYNTHETIC SUBSTITUTES
|
|
